US Officials to Correct Misinformation on Nicotine E-Cigarettes

Dec.13.2022
US Officials to Correct Misinformation on Nicotine E-Cigarettes
US tobacco researchers ask CDC for correct information on e-cigarettes, with health officials correcting misleading public health statements.

Tobacco researchers in the United States have consulted with the Centers for Disease Control and Prevention (CDC). The US Secretary of Health will address some incorrect information released by public health agencies regarding nicotine e-cigarettes.


US Health Secretary Vivek Murthy has recently launched an initiative to reduce the spread of health misinformation in light of the COVID-19 pandemic. As part of this effort, he has advised public health institutions such as the Centers for Disease Control and Prevention (CDC) to stop promoting inaccurate information about electronic cigarettes. For instance, the CDC had disseminated misleading information about the lung injuries caused by e-cigarettes in 2019 (EVALI), and the Health Secretary's report about youth e-cigarette use in 2016 had wrongly claimed that nicotine e-cigarettes were the most commonly used among young people.


The call was made in an editorial published in the Addiction journal. It was co-written by Michael Pesko, a health economist at Georgia State University, along with colleagues from Harvard Medical School, Pennsylvania State University, the Medical University of South Carolina and the University of Michigan. Tom Miller, the former chairman of the Truth Initiative board and Iowa's attorney general, was also a co-author.


The author of the editorial explained that the Center for Disease Control (CDC) named the lung injury of 2019 related to the usage of e-cigarettes as "EVALI" and refused to change the name, which led to widespread attention and misunderstanding from the public and scientific community about the cause of the disease.


It has been reported that the current director of the FDA's Center for Tobacco Products, Brian King, coined the term "EVALI." King is a staunch opponent of nicotine e-cigarettes and was formerly an employee in the smoking and health office at the Centers for Disease Control and Prevention.


The name EVALI has been indirectly responsible for the deaths of 68 people and has sent thousands to hospital, as they were not given a clear warning by public health officials about the risks associated with unregulated electronic cigarettes containing THC oil.


According to the author, all evidence indicates that the illegal tetrahydrocannabinol (THC) e-cigarettes contaminated with vitamin E acetate are the main risk factor for illness, but there is no research indicating any chemicals found in nicotine e-cigarettes. Vitamin E acetate is insoluble in nicotine e-liquid and has never been detected in nicotine e-cigarettes.


The author suggests that despite evidence to the contrary, the Center for Disease Control (CDC) continues to include e-cigarettes in the EVALI designation. This naming convention has had an impact on news reporting and has contributed to a distorted belief among consumers that using nicotine e-cigarettes is risky.


In 2021, the same author officially requested that the Centers for Disease Control and Prevention trace a change in the name "EVALI," removing "e-cigarette" from the name and adding "adult THC.


2FIRSTS will continue to report on this topic, with further updates available on the "2FIRSTS APP". Scan the QR code below to download the app.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Seoul to Fine Use of Liquid E-Cigarettes in No-Smoking Areas From April 24
Seoul to Fine Use of Liquid E-Cigarettes in No-Smoking Areas From April 24
Seoul will begin fining the use of all tobacco products, including liquid e-cigarettes, in no-smoking areas from April 24, when the revised Tobacco Business Act takes effect.
Apr.09 by 2FIRSTS.ai
Ukrainian Lawmaker Proposes Ban on Vapes, Heated Tobacco Devices and Hookahs for Under-17s
Ukrainian Lawmaker Proposes Ban on Vapes, Heated Tobacco Devices and Hookahs for Under-17s
Ukraine’s Verkhovna Rada has registered a bill that would ban the use of tobacco products, vapes, hookahs, herbal smoking mixtures and heated tobacco devices by people under 17. The bill was introduced by People’s Deputy Georgiy Mazurashu and has already been sent to the relevant parliamentary committee. The author said one reason for the initiative is the prevalence of vaping among adolescents.
Apr.28 by 2FIRSTS.ai
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Summary Ispire Technology announced a strategic joint venture with Chinese pharmaceutical company Jincheng Pharma to manufacture and commercialize nicotine pouch products. The partnership combines pharmaceutical-grade production capabilities with Ispire’s global regulatory infrastructure and distribution network as the company expands beyond vaping hardware into oral nicotine products.
Business
May.13
Imperial Brands Pulls myblu Vape Business From U.S., Citing Prolonged FDA Approval Process
Imperial Brands Pulls myblu Vape Business From U.S., Citing Prolonged FDA Approval Process
Imperial Brands said it will phase out its myblu vaping business in the United States, citing prolonged FDA approval timelines for new vape products. The company said it will instead focus on modern oral nicotine products in the U.S., including the expansion of its Zone brand and new flavors. While overall next-generation product revenue continued to grow, revenue from the category in the Americas declined sharply.
May.12
Altria Announces Nationwide Retail Expansion of on! PLUS Nicotine Pouches
Altria Announces Nationwide Retail Expansion of on! PLUS Nicotine Pouches
Altria Group, Inc. announced the nationwide retail expansion of on! PLUS nicotine pouches, a product manufactured by Helix Innovations LLC, an Altria operating company. The product had already been available through e-commerce and participating retailers in North Carolina, Florida and Texas, began wholesale deliveries on March 16, 2026, and is expected to reach participating retailers nationwide starting March 23, 2026.
Mar.24 by 2FIRSTS.ai
Imperial Brands Expands Blu Fruit-Flavour Offerings Following Consumer Preference Data
Imperial Brands Expands Blu Fruit-Flavour Offerings Following Consumer Preference Data
Imperial Brands has announced the launch of a new Sour Berry flavour for its Blu vape range. The product will launch across retail this month, with both the Blu bar kit and Blu pod pack carrying a recommended retail price of GBP 5.99 (approximately USD 7.79, based on 1 GBP ≈ 1.30 USD).
Apr.03 by 2FIRSTS.ai